The 2024 ESC Guidelines for the management of atrial fibrillation, developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), contain a number of
There was no difference in major post-operative complications in patients who continued vs. stopped renin-angiotensin system inhibitors (RASIs) before non-cardiac surgery, according to late-breaking research
Semaglutide, the popular anti-obesity drug, reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established cardiovascular disease
U.S. regulators have cleared a third updated Covid-19 vaccine for this fall, shots made by Novavax. Already, Pfizer and Moderna are shipping shots modified to better match
Two nurses preparing a patient for hemodialysis. The latest Flow trial data indicates Novo Nordisk’s Ozempic (semaglutide) can benefit patients with chronic kidney disease. Image
Nipocalimab is an IgG receptor FcRn large subunit p51 antagonist designed to compete with IgG in binding to FcRn. Credits: Skorzewiak/Shutterstock.com Johnson & Johnson (J&J)
Amvuttra showed a significant reduction in mortality and cardiovascular events for ATTR amyloidosis with cardiomyopathy patients in the Helios B trial. Credit: Tada Images via
The European Society of Cardiology Congress 2024 is taking place in London 30 August- 2 September. Obesity is an independent risk factor for heart failure,
What You Should Know: – Medscape has launched a free AI medical scribe for US physicians, the latest entry in a developing space of artificial intelligence tools
What You Should Know: – The Medical University of South Carolina (MUSC), South Carolina’s only comprehensive academic health system, announced it is expanding its efforts to